Team Reveals Weak Spots in Ebola’s Defenses

The new study from the Ward and Saphire labs exposes how experimental drug ZMapp attacks the virus and suggests strategies to improve future therapies.

Researchers Discover New Type of Neuron that Plays Key Role in Nicotine Addiction

“If we can find a way to target those neurons in humans, maybe we can reduce the ‘high’ produced by the drug and reduce the withdrawal symptoms,” says Assistant Professor Olivier George.

Cells' Response to Chronic Protein Misfolding May Do More Harm than Good

The study from the Balch lab suggests diseases such as cystic fibrosis and Alzheimer’s can be seriously exacerbated by the body’s response, providing fundamental insights with implications for the design of new therapies.

Physician-Scientist Shares His Journey to Help Those with Autoimmune Diseases

Professor Hugh Rosen spoke to donors about his experiences with drug discovery at a recent lecture hosted by TSRI’s Office of Philanthropy.